How Synopsys Bet $35B on Ansys to Redraw the Map of Chip Design

The EDA industry is a roughly $15B global software market that sits at the choke point of the broader $500B semiconductor industry. Three vendors, Synopsys, Cadence and Siemens EDA, control approximately 75% of the market in a tight oligopoly. Demand has accelerated since 2022 on the back of the AI accelerator wave and the move to 3nm, 2nm and beyond. The multiphysics simulation industry is a separate but adjacent ~$8B market, where Ansys holds roughly 30% share and competes with Dassault Systèmes (Abaqus), Siemens (Simcenter) and Hexagon (MSC). Historically these were distinct markets. Advanced-node co-design of chip, package and system has driven rapid convergence between them, and the Synopsys-Ansys combination is the formal acknowledgment of that convergence by the leading vendor on the EDA side.

Inside the EDA Big Three, Synopsys is strongest in synthesis and sign-off, Cadence in custom analog and simulation, and Siemens EDA in PCB and system IC. The Ansys deal lets Synopsys leap straight to vertical integration of EDA and multiphysics simulation, pressuring Cadence in particular. Cadence responded in 2024 by acquiring BETA CAE Systems for approximately $1.24B to enter structural simulation. The Big Three are converging from pure EDA vendors toward integrated design and simulation platforms.

Ansys was founded in 1970 by mechanical engineer John Swanson as Swanson Analysis Systems, Inc. (SASI), renamed to ANSYS in 1994, and listed on NASDAQ in 1996. Its portfolio spans more than fifty solvers across structural mechanics (Mechanical), computational fluid dynamics (Fluent), electromagnetics (HFSS, Maxwell), semiconductor sign-off (RedHawk, Totem) and system simulation (SCADE, Twin Builder). The company is embedded in automotive (EV battery thermal management, BMS design), aerospace (F-35 stealth design, SpaceX vehicle CFD), semiconductor packaging (2.5D and 3D warpage and power integrity) and medical devices (MRI field simulation). Fiscal 2023 revenue was approximately $2.27B with GAAP operating income of about $670M (28% margin) and non-GAAP operating margin near 42%. Ansys employed roughly 6,500 people globally, headquartered in Canonsburg, Pennsylvania.

Revenue by Segment (FY2023)

FY2023 estimated breakdown. Lease (subscription) plus Maintenance represent roughly 80% of revenue, reflecting an accelerating SaaS-style transition.

The transaction is structured as a cash-and-stock merger. Each Ansys common share is converted into $197.00 in cash plus 0.3450 Synopsys common shares. At the announcement-day Synopsys closing price of approximately $501, the implied per-share consideration was around $370 ($197 cash plus $172.85 in stock), a roughly 29% premium to Ansys's $287 undisturbed close. Financing comprises approximately $19.5B in cash (existing Synopsys balance sheet plus new debt) and approximately $15.5B in equity through about 100 million newly issued Synopsys shares. Following closing, legacy Synopsys shareholders own about 83.5% and former Ansys shareholders about 16.5% of the combined company. Synopsys is the surviving legal entity, with Ansys becoming a wholly owned subsidiary headquartered out of Synopsys's Mountain View, California campus.

Both sides retained tier-one advisors familiar with megacap technology M&A. The four-jurisdiction antitrust review (US, EU, UK, China) made antitrust counsel as critical as classical M&A advisory throughout the eighteen-month process.

Advisor information sourced from official press releases and SEC filings; secondary advisors may be omitted.

USD millions, US GAAP basis, from Ansys 10-K and 8-K filings. FY2020 revenue softened on COVID-19 impact; FY2021 onward reflects accelerating subscription mix.

The headline pricing works out to approximately 15× run-rate combined EBITDA. On Ansys-standalone FY2023 EBITDA of about $820M, the $35B enterprise value implies roughly 42×, an optically expensive number. Synthesizing in Synopsys's stated synergy targets (more than $400M of annual revenue synergies and roughly $400M of annual cost synergies, both phased over three years) brings the implied multiple on combined run-rate EBITDA close to 15×, within the 15-20× range typical for EDA and simulation software. The thesis is less about earnings compounding from the existing footprint and more about owning the integrated chip-to-system design platform that becomes the de facto standard at 3nm, 2nm and 1.4nm.

Synergy figures reflect Synopsys IR guidance. EBITDA includes some non-GAAP estimates.

About eleven months after closing, integration has tracked Synopsys's IR guidance more closely than skeptics expected. In January 2026 Synopsys announced approximately 2,000 layoffs across the combined ~25,000-person organization (around 8%), concentrated in duplicative R&D, sales and G&A functions, the textbook execution of the cost-synergy plan. Revenue synergies are emerging in automotive and semiconductor packaging accounts but the bulk of the cross-sell ramp is expected in 2026-2027. The bigger question is how the AI chip cycle evolves after its 2025-2026 peak; that variable, more than integration mechanics, will dictate combined-company growth through the end of the decade. Separately, the FTC's structural-remedy consent decree (Keysight divestitures) has been cited repeatedly by antitrust practitioners as the first major proof point that the FTC has shifted back from behavioral to structural remedies as its default merger toolkit.